Average Co-Inventor Count = 3.24
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ardea Biosciences, Inc (20 from 63 patents)
2. Valeant Pharmaceuticals International (12 from 22 patents)
3. Merck + Co., Inc. (7 from 4,770 patents)
4. Sibia Neurosciences, Inc. (5 from 48 patents)
5. Merck Sharp + Dohme Corp. (4 from 2,405 patents)
6. Oncternal Therapeutics, Inc. (3 from 16 patents)
7. Erasca, Inc. (2 from 2 patents)
8. Bayer Schering Pharma Ag (1 from 192 patents)
9. Alla Chem, LLC (1 from 3 patents)
10. Selexagen Therapeutics, Inc. (1 from 1 patent)
56 patents:
1. 12162893 - Tricyclic pyridones and pyrimidones
2. 11845761 - Tricyclic pyridones and pyrimidones
3. 10919858 - Thioacetate compounds, compositions and methods of use
4. 10266493 - Thioacetate compounds, compositions and methods of use
5. 9987251 - Indolinone compounds and uses thereof
6. 9895352 - Indolinone compounds and uses thereof
7. 9604927 - Indolinone compounds and uses thereof
8. 9212135 - Phenylthioacetate compounds, compositions and methods of use
9. 9174949 - Hedgehog inhibitors
10. 8993593 - N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
11. 8829052 - Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
12. 8722929 - N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
13. 8716318 - Pyridone sulfonamides and pyridone sulfamides as MEK inhibitors
14. 8673919 - Dihydropyridin sulfonamides and dihydropyridin sulfamides as MEK inhibitors
15. 8648116 - Derivatives of N-(arylamino) sulfonamides including polymorphs as inhibitors of MEK as well as compositions, methods of use and methods for preparing the same